PPARgamma3 mRNA: a distinct PPARgamma mRNA subtype transcribed from an independent promoter. - Wikidata - wikimedia - TriplyDB

PPARgamma3 mRNA: a distinct PPARgamma mRNA subtype transcribed from an independent promoter.

PPARgamma3 mRNA: a distinct PPARgamma mRNA subtype transcribed from an independent promoter.

http://www.wikidata.org/entity/Q40994024

about

Peroxisome proliferator-activated receptors (PPARs) and ovarian function--implications for regulating steroidogenesis, differentiation, and tissue remodeling.The Role of PPARs in Cancer The role of peroxisome proliferator-activated receptors in carcinogenesis and chemoprevention PPARgamma1 and LXRalpha face a new regulator of macrophage cholesterol homeostasis and inflammatory responsiveness, AEBP1 The pathophysiological function of peroxisome proliferator-activated receptor-gamma in lung-related diseases.PPARγ as a Novel Therapeutic Target in Lung Cancer PPARγ in Bacterial Infections: A Friend or Foe?Molecular targets of dietary polyphenols with anti-inflammatory properties 'Striking the Right Balance' in Targeting PPARgamma in the Metabolic Syndrome: Novel Insights from Human Genetic Studies The non-genomic crosstalk between PPAR-gamma ligands and ERK1/2 in cancer cell lines A Novel Splicing Variant of Peroxisome Proliferator-Activated Receptor-γ (Pparγ1sv) Cooperatively Regulates Adipocyte Differentiation with Pparγ2 Pharmacological peroxisome proliferator-activated receptorgamma ligands: emerging clinical indications beyond diabetes.Association between the Pro12Ala polymorphism of the peroxisome proliferator-activated receptor gamma gene and strength athlete status.Peroxisome proliferator-activated receptor delta (PPARdelta )-mediated regulation of preadipocyte proliferation and gene expression is dependent on cAMP signaling.Peroxisome proliferator-activated receptor-gamma: a versatile metabolic regulator.Peroxisome proliferator-activated receptors in tumorigenesis: targets of tumour promotion and treatment.Peroxisome proliferator activated receptor-γ and traumatic brain injury.The Pro12Ala Polymorphism of the Peroxisome Proliferator-Activated Receptor Gamma Gene Modifies the Association of Physical Activity and Body Mass Changes in Polish Women.Antiproliferative and apoptotic effects of telmisartan in human colon cancer cells.Adipocyte enhancer-binding protein 1 is a potential novel atherogenic factor involved in macrophage cholesterol homeostasis and inflammation Activation of PPAR{gamma} by curcumin inhibits Moser cell growth and mediates suppression of gene expression of cyclin D1 and EGFR.Peroxisome proliferator-activated receptor gamma agonists: potential use for treating chronic inflammatory diseases.Xenobiotic metabolism, disposition, and regulation by receptors: from biochemical phenomenon to predictors of major toxicities PPARgamma and the thiazolidinediones: molecular basis for a treatment of 'Syndrome X'?Anticancer actions of PPARγ ligands: Current state and future perspectives in human lung cancer Resolving the Two "Bony" Faces of PPAR-gamma.The Genetics of PPARG and the Skeleton.PPARgamma and metabolism: insights from the study of human genetic variants.Deletion of PPAR-γ in immune cells enhances susceptibility to antiglomerular basement membrane disease Peroxisome proliferator-activated receptor gamma: the more the merrier?The role of peroxisome proliferator-activated receptors in the esophageal, gastric, and colorectal cancer Function of PPARgamma and its ligands in lung cancer.Peroxisome proliferator-activated receptors in lung cancer.PPARgamma2 Regulates a Molecular Signature of Marrow Mesenchymal Stem Cells.PPAR Action in Human Placental Development and Pregnancy and Its Complications.PPAR Gamma: Coordinating Metabolic and Immune Contributions to Female Fertility.Thiazolidinediones: effects on insulin resistance and the cardiovascular system.Investigational PPAR-gamma agonists for the treatment of Type 2 diabetes.Drug insight: thiazolidinediones and diabetic nephropathy--relevance to renoprotection.Thiazolidinediones: potential as therapeutics for psoriasis and perhaps other hyperproliferative skin disease.

P2860

Q21245560-556D0668-8A89-4ED5-987F-F37256AB2A08 Q21342955-B64E65CE-149D-4433-A861-70F4D9B77887 Q24601222-85AD27B1-21E2-4891-BA82-4C29D2CDE102 Q24633440-C9B8B8F2-A382-4B47-83C1-2D443DAAF710 Q24814517-60C0F19F-5B63-4F5A-8EDC-977AF087D989 Q28068114-36A4ABE1-DEB7-4EAD-84E8-6B8E97E3465D Q28070173-0BABB844-75D5-438B-8471-58BEEB23024E Q28192995-EEB66B32-7812-40AE-8C13-D4E092024547 Q28221639-7550F8CB-3DAC-4659-9476-CD90CBF82FE5 Q28238709-DD4460A0-DCF3-4F30-9A5B-E5CC0D933854 Q28508444-ACC316B2-1B31-45E6-B396-BB3FE1846AD3 Q30977623-1AECD03E-47F7-4003-AE2A-8C785C08AB30 Q31121358-E4A4B6FB-CC42-431B-A80A-FC258C0D2A91 Q31537639-5C6018A2-89B1-42DA-A8D2-F61C7F077935 Q33780711-F69C5797-81D2-4D36-9950-8A88E6DA9A75 Q34007479-476CE0EA-297D-4245-A4C1-76D2828BB2AE Q34271250-B4F566AC-88AD-495D-8B20-F03EB446D7E4 Q34412598-50C7E69F-615F-441D-9BCF-66C50BC9E8AA Q34445703-93C7CC03-0C72-4EB9-A15F-76A978881AB2 Q34478995-9761B08B-4984-47E7-AAC0-C0702F88CA87 Q34551882-D260204D-E5BB-4BDC-AEBE-003F18659C37 Q34580424-910E4772-04AD-4FAD-87AB-15BD8039091D Q34625038-04D87D3E-0B89-4C80-ACFB-31AA9DFCF600 Q34722604-0A90F34C-9778-4ABC-BA3E-17563F184086 Q34878637-1DFE9A8F-A0E1-4486-BD21-F605DA209608 Q35191573-6D561BC2-E645-4BA9-9B78-A88F44ECB3C4 Q35191583-A2A7D69C-A48F-4A05-8DCD-B8FE9335DD30 Q35200033-3B278C7E-2075-41B3-8305-19FAA139164C Q35557407-18C29949-DA9E-4BF2-9376-4EB1D94D9A93 Q36018557-3BE8FCE0-A87C-4CDE-9F8F-8DD1B49CC5B9 Q36238973-7077BA0E-81E7-46E5-B091-C4F76FE3E965 Q36414175-D102AEB4-07D9-461E-83F0-99C11DA93F70 Q36417658-BBD379D9-2589-45D6-AF9D-49089AC4048F Q36446012-E6EBE5C4-D696-4860-8D9D-343A016B707E Q36446678-6AEE33C6-C9F1-403C-8F39-3F294E839CF3 Q36465006-29255B2A-40EA-46D5-B566-1CDE0BDDB997 Q36484662-3663C69B-26C8-438F-967D-19994D37F730 Q36512559-6B40A4CD-1A43-480F-A325-6815A512DDD8 Q36577073-E3E69D9C-1D4F-435F-BA5A-53A95F6851AB Q36623091-2D20CBB6-21F2-4652-8071-287042C21BFD

P2860

PPARgamma3 mRNA: a distinct PPARgamma mRNA subtype transcribed from an independent promoter.

http://www.wikidata.org/entity/Q40994024

description

1998 nî lūn-bûn

@nan

1998年の論文

@ja

1998年論文

@yue

1998年論文

@zh-hant

1998年論文

@zh-hk

1998年論文

@zh-mo

1998年論文

@zh-tw

1998年论文

@wuu

1998年论文

@zh

1998年论文

@zh-cn

name

PPARgamma3 mRNA: a distinct PP ...... from an independent promoter.

@en

type

label

PPARgamma3 mRNA: a distinct PP ...... from an independent promoter.

@en

prefLabel

PPARgamma3 mRNA: a distinct PP ...... from an independent promoter.

@en

P1433

Q40994024-B83BBEA8-2AA5-4EAD-BD6D-55E36C53CADC

P1476

Q40994024-CE7903A4-870C-4C5E-AA52-BBFECE8EEDC4

P2093

Q40994024-E854D9EB-7790-4ADE-BB31-4C4B18809298

Q40994024-F4AB2BF0-3F3B-435E-ABA9-7298C42AD381

P2860

Q40994024-12343EBB-BCF2-4697-8EB4-E0FABEAB2135

Q40994024-3892B9AE-79FE-4F2D-B7EB-270956304483

Q40994024-43A8E369-6949-411F-AF11-3FF73F3843D7

Q40994024-5814525F-A319-44E6-A761-6B3C6080A599

Q40994024-5ABC4E57-5E76-46FD-94B9-C85A3A475D8C

Q40994024-6FA30DFB-2BED-4365-92A9-781F0E7B4657

Q40994024-727AB3D4-97A9-42FC-9E02-A83898B75335

Q40994024-805F063B-C2E8-4904-944F-1DD1C3633AC2

Q40994024-8C6EFB1C-36F8-4CCB-A396-4A5329A5C4B8

Q40994024-990F81C3-A9A9-480C-BB13-FE8AB76C6789

P304

Q40994024-17B3B9A6-E21F-471F-8319-4A4B54218DC8

P31

Q40994024-39A911AF-DA09-405A-A96B-793EAE935FE7

P356

Q40994024-BB94F6A3-A081-4DF9-9AA2-62FDE4138A72

P407

Q40994024-8FF388F0-A830-4BA5-AB3C-22536BD02B73

P433

Q40994024-8A52DC11-110B-42D1-9006-264C6D21DF0D

P478

Q40994024-FFF23577-CFB1-4AC1-9C3D-B6A0090A7D02

P50

Q40994024-F22E241D-3032-4437-970E-3AD550370056

P577

Q40994024-573CB723-6D4D-450B-AD82-D95EB1827F77

P698

Q40994024-1CF592D3-DC45-46DE-BAE1-4A8FC59F97D8

P356

S0014-5793(98)01273-3

P1433

P1476

PPARgamma3 mRNA: a distinct PP ...... from an independent promoter.

@en

P2093

Fajas L

http://www.w3.org/2001/XMLSchema#string

Fruchart JC

http://www.w3.org/2001/XMLSchema#string

P2860

Purification, cloning, and RXR identity of the HeLa cell factor with which RAR or TR heterodimerizes to bind target sequences efficiently

The organization, promoter analysis, and expression of the human PPARgamma gene

Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid-activated transcription factor

15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma

An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma)

mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer

A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor gamma and promotes adipocyte differentiation

Transient increase in obese gene expression after food intake or insulin administration.

CAP and RNA polymerase interactions with the lac promoter: binding stoichiometry and long range effects.

Fibrates increase human apolipoprotein A-II expression through activation of the peroxisome proliferator-activated receptor

P304

55-60

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/S0014-5793(98)01273-3

http://www.w3.org/2001/XMLSchema#string

P407

P433

1-2

http://www.w3.org/2001/XMLSchema#string

P478

438

http://www.w3.org/2001/XMLSchema#string

P50

P577

1998-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

9821958

http://www.w3.org/2001/XMLSchema#string